Currently Viewing:
Newsroom
Currently Reading
ELOQUENT-3: Adding Elotuzumab to Pomalidomide, Dexamethasone Improves PFS in R/R Multiple Myeloma
December 08, 2018 – David Bai, PharmD
Studies Show Medicaid Expansion Is Improving Health, While Jury Still Out on Chronic Disease
December 07, 2018 – Mary Caffrey
Continuous Infusion of Recombinant Activated Factor VII Safe, Effective in Management of Congenital Hemophilia
December 07, 2018 – Jackie Syrop
Study Identifies COPD Patient Subgroup Who Benefit Most From Roflumilast
December 07, 2018 – Alison Rodriguez
Researchers Demonstrate Efficacy of EEG-Based Test for Measuring Pain
December 07, 2018 – Alison Rodriguez
European Stakeholders Appeal EPO Ruling to Uphold Gilead's Sofosbuvir Patent
December 07, 2018 – Samantha DiGrande
5 Things to Know About Getting the Flu Shot
December 07, 2018 – Samantha DiGrande
CMS Finalizes Risk-Adjustment Rule for 2018 Benefit Year
December 07, 2018 – Allison Inserro
International Consensus on Timely Care for Multiple Sclerosis
December 07, 2018 – David Bai, PharmD

What We're Reading: HealthCare.gov Maintenance; USMCA Drug Exclusivity; Medicare Telemedicine Proposal

AJMC Staff
When consumers try to sign up for Affordable Care Act health plans on the federal marketplace, they may encounter hours-long downtime for the site; the United States–Mexico–Canada Agreement would increase pharmaceutical exclusivity from 8 years to 10 years, delay access to competition from biosimilar biologics; Medicare is considering paying for telemedicine for a 5-minute check-in call, but physicians question the proposal.

Administration Plans HealthCare.gov Maintenance During Open Enrollment

When consumers try to sign up for Affordable Care Act health plans on the federal marketplace, they may encounter hours-long downtime for the site. According to The Hill, the Trump administration is planning to take the site down for maintenance from 12 am to 12 pm each Sunday, except for the last Sunday, during the sign-up period. The maintenance schedule is the same as last year’s, which had drawn criticism from advocates who said the planned maintenance during open enrollment would hinder efforts to sign people up for coverage.

 

NAFTA Replacement Could Thwart Biosimilars

The United States–Mexico–Canada Agreement, or USMCA, updates the North American Free Trade Agreement and increase pharmaceutical exclusivity from 8 years to 10 years. The new deal allows US drug companies to sell pharmaceutical products in Canada for 10 years without generic or biosimilar competition, according to The Center for Biosimilars®, a sister site of The American Journal of Managed Care®. The concern is that USMCA will delay access to competition from biosimilar biologics, which can increase costs for patients and payers, but benefit the pharmaceutical industry. The Pharmaceutical Research and Manufacturers of America (PhRMA) supported the agreement and the intellectual property protections, which PhRMA President and CEO Stephen J. Ubl called the “lifeblood” of the biopharmaceutical industry.

 

Physicians Question Medicare’s Proposed Telemedicine Reimbursement

Medicare is considering paying for telemedicine by reimbursing doctors $14 for a 5-minute check-in call with patients. However, many physicians are unhappy that patients would be required to pay a 20% cost-sharing charge. Kaiser Health News reported that many physicians who provide telemedicine services do so for free. Less than 1% of Medicare beneficiaries use telemedicine services annually. Under the Medicare reimbursement the call would be used to determine if patients need to come in for an appointment, but virtual sessions can cover an array of services including monitoring patients on a new medicine or helping patients to manage a chronic disease.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!